ArticleChildren (Basel, Switzerland)2025

Retrospective Study of Severe Atopic Disease in Young Children (0-5 Years) Managed with Dupilumab Highlights Significant Comorbidities.

Evelyn F Fagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.